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1.1. Macrocyclic antagonist to the human motilin receptor
Macrocyclisation has been used in drug discovery to
provide peptidic materials with reduced conformational
ﬂexibility, higher receptor aﬃnity and reduced metabolic
vulnerability. However, macrocycles as a class are diﬃcult
to generate in large numbers and have rarely been made in
a combinatorial fashion. A recent paper describes the gen-
eration of library of macrocyclic peptidomimetics and their
use in the discovery of potent antagonists of the human
motilin receptor.1
Motilin is a 22-amino acid peptide that is released from
endocrine cells in the gut wall and is involved in the control
of gastrointestinal (GI) tract motility. The G-protein cou-
pled receptor for motilin is found in the duodenum, antrum
and nearby small intestine, and activation results in peri-
staltic contractions that propel gut contents along the GI
tract. Inhibitors of the motilin receptor could have utility
for a number of GI complaints.doi:10.1016/j.comc
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(1)A library of macrocycles has been prepared and screening
of this collection in a high-throughput ﬂuorescence-basedhe.2007.03.001
nsemblediscovery.comwhole cell assay revealed a cyclic tripeptide hit (1) with
antagonistic activity (Ki 137 nM). Modiﬁcation of this lead
compound took place by the use of two complementary
solid-phase synthetic approaches: method A involved a
macrolactamisation cyclative release and method B, a
ring-closing metathesis cyclative release strategy. By releas-
ing products from the solid support on cyclisation, it
resulted in materials of higher purity which were screened
to establish SAR against the motilin receptor. Overall, a
17-fold improvement in binding aﬃnity was obtained by
modiﬁcation of all four points of diversity in the macro-
cyclic structure, and furthermore, isosteric replacements
to the amide bonds were investigated.
1.2. On-bead library screening seeking selective aldose
reductase inhibitors
Under the hyperglycaemic conditions found in diabetes,
glucose is directed through the polyol pathway, ﬁrstly by
reduction by aldose reductase 2 (ALR2) to sobitol, and
then subsequent reoxidation by sobitol dehydrogenase to
fructose. As the latter enzyme is rate-limiting, the accumu-
lation of sobitol in cells gives rise to osmotic or redox
imbalances resulting in many of the complications associ-
ated with diabetic hyperglycaemia. Inhibitors of ALR2
could be eﬀective in treating the secondary diabetic compli-
cations, and a recent report describes the use of combina-
torial chemistry in the search for new inhibitors.2
On-bead screening of one-bead one-compound combinato-
rial libraries has been shown to be an eﬀective way of ﬁnd-
ing novel compounds with pharmacological activity. A
library of potential ALR2 inhibitors was constructed on
TentaGel resin beads using a diﬀerential protecting strat-
egy to discriminate between target compounds on the bead
surface, and MALDI-TOF mass spectrometry encoding
sequences on the bead interior. Various building blocks
were incorporated to ensure suﬃcient solubility in the ﬁnal
compounds.
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(2)The library was screened against diﬀerentially ﬂuoresecent
dye labelled ALR1 and ALR2, and active compounds de-
coded by reference to the mass tag reference compound.
Several compounds exhibited selective inhibition of
ALR2 including (2) which revealed a Ki value of 1.6 lM
versus DL-glyceraldehyde. Overall, the on-bead assay used
provided novel inhibitors with greater than 7000-fold selec-
tivity for ALR2 over ALR1.2. A summary of the papers in this month’s issue
2.1. Solid-phase synthesis
A new approach has been described for the general Fmoc-
based solid-phase synthesis of C-terminal peptide (thio)-
esters. One hydroxy group of 2,2-dithiodiethanol (used in
large excess) was anchored on trityl resin, and the remain-
ing hydroxy group was loaded with the ﬁrst amino acid.
Standard chain elongation and TFA-based peptide release
yielded peptide C-terminal dithiodiethanol esters in good
purities.3
Soluble and polymer-supported 2- and 3-benzylated furans
have been subjected to a sequence involving a Diels–Alder
reaction with a,b-acetylenic carbonyl compounds, a
Michael addition, and a subsequent retro-Diels–Alder
reaction to yield oleﬁnic compounds. On solid support, this
traceless strategy is advantageous since pure compounds
were released in the thermal cycloreversion step.4
2.2. Solution-phase synthesis
A small library of meta- and para-biphenylamines substi-
tuted by various alkyl, alkoxy, phenoxy, or halogeno
groups on their aromatic rings have been synthesised via
Suzuki–Miyaura cross-coupling between bromoanilines
and arylboronic acids using palladium catalysts.5
2.3. Scaﬀolds for combinatorial libraries
A new and versatile synthesis of imidazo[1,2-c]pyrimidines
via a [4+1]-cycloaddition has been described. The reported
novel synthetic approach leads to pharmacologically
interesting scaﬀolds containing three points of potential
diversity, which previously were not accessible under
conventional conditions.6
A three-component condensation of 5-amino-3-methyl-
pyrazole, tetronic acid, and various aromatic, heteroaro-matic, and aliphatic aldehydes leads to the formation of
dihydropyridopyrazole analogues of a cytotoxic lignan
podophyllotoxin. This new heterocyclic scaﬀold-based
library allows a drastic reduction of the structural complex-
ity of the natural product with the retention of its potent
cytotoxic properties.7
A novel complexity-generating reaction has been described,
which can be used in a high-throughput parallel solution-
phase combinatorial format. The synthetic pathway fea-
tures the Ugi four component reaction followed by intra-
molecular cyclisation via C–C bond formation. Starting
from readily available initial reactants, the described
approach leads to generation of novel 3-oxoisoindoline-1-
carboxamides with four points of diversity around the core
scaﬀold.82.4. Solid-phase supported reagents
No papers this month.2.5. Novel resins, linkers and techniques
A rapid and convenient one-pot route to solid supported
benzhydrylamine linkers with high chemical loading has
been described. Such linkers possess diﬀering levels of acid
lability, which could be exploited in solid phase synthesis
applications.9
A new colorimetric test (methyl red-DIC test) for monitor-
ing the presence of hydroxyl groups on resins for use in
solid-phase synthesis has been developed. The resin became
orange-red when the carboxyl group of methyl red formed
ester linkages with the resin’s hydroxyl groups.10
The use of a p-nitrophenyl ester, previously developed for
the detection of free aliphatic amines on solid support,
has been shown to oﬀer a reliable method for the detection
of free aromatic amines.112.6. Library applications
A new publication describes, for the ﬁrst time, the synthesis
and SAR, developed through an iterative analogue library
approach, that led to the discovery of the positive allosteric
modulator of the metabotropic glutamate receptor
mGluR5 CPPHA.12
A high-throughput screening campaign of a library of
100,000 lead-like compounds has identiﬁed 2-iminobenz-
imidazoles as a novel class of trypanothione reductase
inhibitors. These 2-iminobenzimidazoles display potent
trypanocidal activity against Trypanosoma brucei rhodes-
iense, do not inhibit closely related human glutathione
reductase and have low cytotoxicity against mammalian
cells.13
For a glucocorticoid receptor (GR) program, an unex-
plored, synthetically accessible phosphorus-containing
steroidal mimetic of mifepristone, suitable for parallel
analogue synthesis was sought. One compound, with high
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antagonism of GR in oral glucose tolerance test.14
A small library of 2-deacetoxytaxinine J derivatives has
been synthesised and tested in vitro for their reversal activ-
ity in human mammary carcinoma MDR cell line MCF7-
R.15
The discovery, synthesis and structure–activity relationship
(SAR) of novel carboxylic acid agonists for GPR40 have
been described. An arylpropionic acid, identiﬁed from a
high throughput screen, was selected for chemical explora-
tion, and a lead molecule identiﬁed through eﬃcient solid
phase combinatorial array chemistry.16
From chemical compound library screening using an HCV
NS5B RNA-dependent RNA polymerase enzymatic assay,
a substituted quinoxaline hit with an IC50 of 5.5 lM was
identiﬁed. A series of substituted quinoxaline amide deriv-
atives were synthesised based on the hit’s pharmacophore,
and a good structure–activity relationship observed.17
The inhibition of caspase-3 may have an important impact
on the treatment of several degenerative diseases. The syn-
thesis of reversible inhibitors via a solid-supported palla-
dium-catalysed amination of 3-bromopyrazinones and the
discovery of a pan-caspase reversible inhibitor has been
described.18
The multiple parallel synthesis of a series of N,S-bis-alkyl-
ated thiopyrazolo[3,4-d]pyrimidines, based on sequential S-
then N-alkylation, has been reported. These compounds
showed signiﬁcant anti-mycobacterial activity (MICs down
to 62 lg/ml) and their potential as signiﬁcant drug-like
leads is substantiated through cytotoxicity evaluation and
in silico proﬁling.19
In the search for new chemotherapeutic agents useful
against Rubella virus (RV) infections, a solution-phase
parallel approach for the synthesis of a small library of
4-alkylamino-6-(2-hydroxyethyl)-2-methylthiopyrimidines
has been set up. Biological evaluation of the newly synthes-
ised compounds indicated interesting properties as anti-RV
agents with IC50 values in the micromolar range.
20
A 30-membered library of amides based on the potent
urotensin II (UII) receptor agonist FL104, has been syn-
thesised from ten diﬀerent carboxylic acids and three
amines. The synthesised compounds were evaluated for
their UII receptor agonistic activities using a cell-based
assay (R-SAT). The most active compounds were the
4-triﬂuoromethylcinnamic amides of 1-(4-chlorophenyl)-
3-dimethylamino-propylamine and 1-(2-naphthyl)-3-di-
methylamino-propylamine, both showing EC50 values of
130 nM.21
5-Formyl-2 0-deoxyuridine-3 0,5 0-diacetate has been con-
verted to a small library of 5-substituted pyrimidine
nucleoside N-acylamino acid amides by means of a Ugi
multicomponent reaction. Evaluation of these novel 5-
substituted nucleosides against vaccinia virus and cowpox
virus provided one compound with discernable activityagainst cowpox virus but ﬁve- to eightfold less active than
the Cidofovir standard.22References
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